Show simple item record

dc.contributor.authorBermejo-Peláez, David
dc.contributor.authorMedina, Narda
dc.contributor.authorÁlamo, Elisa
dc.contributor.authorSoto-Debran, Juan Carlos
dc.contributor.authorBonilla, Oscar
dc.contributor.authorLuengo-Oroz, Miguel
dc.contributor.authorRodriguez-Tudela, Juan Luis
dc.contributor.authorAlastruey-Izquierdo, Ana 
dc.date.accessioned2023-07-17T07:56:35Z
dc.date.available2023-07-17T07:56:35Z
dc.date.issued2023-02-07
dc.identifier.citationJ Fungi (Basel). 2023 Feb 7;9(2):217.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16252
dc.descriptionThis work was presented in part at 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will take place online from 9 – 12 July 2021. Abstract number 03467.es_ES
dc.description.abstractCryptococcosis is a fungal infection that causes serious illness, particularly in immunocompromised individuals such as people living with HIV. Point of care tests (POCT) can help identify and diagnose patients with several advantages including rapid results and ease of use. The cryptococcal antigen (CrAg) lateral flow assay (LFA) has demonstrated excellent performance in diagnosing cryptococcosis, and it is particularly useful in resource-limited settings where laboratory-based tests may not be readily available. The use of artificial intelligence (AI) for the interpretation of rapid diagnostic tests can improve the accuracy and speed of test results, as well as reduce the cost and workload of healthcare professionals, reducing subjectivity associated with its interpretation. In this work, we analyze a smartphone-based digital system assisted by AI to automatically interpret CrAg LFA as well as to estimate the antigen concentration in the strip. The system showed excellent performance for predicting LFA qualitative interpretation with an area under the receiver operating characteristic curve of 0.997. On the other hand, its potential to predict antigen concentration based solely on a photograph of the LFA has also been demonstrated, finding a strong correlation between band intensity and antigen concentration, with a Pearson correlation coefficient of 0.953. The system, which is connected to a cloud web platform, allows for case identification, quality control, and real-time monitoring.es_ES
dc.description.sponsorshipCrAg LFA tests were provided by IMMY at no cost. This research was funded by Global Action For Fungal Infections (www.GAFFI.org), JYLAG, a charity Foundation based in Geneva, Switzerland, and Fondo de Investigación Sanitaria from Instituto de Salud Carlos III (PI20CIII/00043). D.B.-P. was supported by grant PTQ2020-011340/AEI/10.13039/501100011033 funded by the Spanish State Investigation Agency. J.C.S.-D. was supported by a fellowship from the Fondo de Investigación Sanitaria (grant FI17CIII/00027).es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectLateral flow assay (LFA)es_ES
dc.subjectRapid diagnostic test (POCT)es_ES
dc.subjectSmartphonees_ES
dc.subjectArtificial intelligence (AI)es_ES
dc.subjectCryptococcuses_ES
dc.subjectCryptococcal antigenes_ES
dc.subjectTest line quantificationes_ES
dc.titleDigital Platform for Automatic Qualitative and Quantitative Reading of a Cryptococcal Antigen Point-of-Care Assay Leveraging Smartphones and Artificial Intelligencees_ES
dc.typereview articlees_ES
dc.typevideo
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36836331es_ES
dc.format.volume9es_ES
dc.format.number2es_ES
dc.format.page217es_ES
dc.identifier.doi10.3390/jof9020217es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderAgencia Estatal de Investigación (España) es_ES
dc.contributor.funderGlobal Action For Fungal Infectionses_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2309-608Xes_ES
dc.relation.publisherversionhttps://doi.org/10.3390/jof9020217es_ES
dc.identifier.journalJournal of fungi (Basel, Switzerland)es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PTQ2020-011340/AEI/10.13039/501100011033es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI20-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2020)/PI20CIII/00043es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/FI17CIII/00027es_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional